PatientsVille.com Logo


Albetol Medical Research Studies

Up-to-date List of Albetol Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Albetol Medical Research Studies

Rank Status Study
1 Recruiting Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.
Conditions: Hypertension, Pregnancy Induced;   Hydralazine Adverse Reaction;   Pre-eclampsia;   Pre-eclampsia Superimposed Pre-existing Hypertension
Interventions: Drug: Labetalol;   Drug: Hydralazine
Outcome Measures: Sever persistent hypertension;   Efficacy (Reduction in blood pressure below thresholds).;   Maternal tachycardia;   Bradycardia;   Bronchospasm;   Maternal hypotension
2 Recruiting Labetalol and Esmolol: Vital Signs and Post Operative Pain Management
Condition: Ambulatory Surgical Procedures
Interventions: Drug: Fentanyl;   Drug: Labetalol;   Drug: Esmolol
Outcome Measures: Postoperative pain using a Verbal Rating Scale;   Opioid consumption obtained from the recorded data;   Postoperative nausea and vomiting using a Verbal Rating Scale;   Return to normal activities of daily living using follow up questionnaires;   Patient satisfaction using a verbal rating scale from 0 to 100;   Hospital stay
3 Unknown  Nicardipine Versus Labetalol During Intubation
Conditions: Patients Who Are Intubated for General Anesthesia;   Endotracheal Intubation
Interventions: Drug: labetalol;   Drug: nicardipine
Outcome Measure: hemodynamic variables (systolic blood pressure, diastolic blood pressure and mean blood pressure, heart rate)
4 Recruiting Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
Conditions: Hypertension in Pregnancy;   Preeclampsia
Interventions: Drug: Nifedipine;   Drug: Labetalol;   Drug: Methyldopa
Outcome Measures: Successful outcome;   number of hourly BP's in severe range
5 Recruiting Intensive Arterial Pressure Control in Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Isosorbide Dinitrate;   Drug: Labetalol
Outcome Measures: mortality;   recurrence of chest pain;   Acute Coronary Syndrome complication;   revascularisation;   stroke;   non cardiac deaths
6 Recruiting Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
Conditions: Ischemic Stroke;   High Blood Pressure
Interventions: Drug: Low-dose rtPA;   Drug: Standard-dose rtPA;   Other: Intensive blood pressure (BP) lowering;   Other: BP management policies
Outcome Measures: Combined death and any disability;   Symptomatic intracerebral hemorrhage;   Intracerebral hemorrhage of any type in CT scans;   Death or disability by the alternative, but less widely used, shift analysis;   Death;   Disability;   Neurological deterioration;   Health-related quality of life;   Admission to residential care;   Health service use
7 Unknown  Treatment Targets for Chronic Hypertension in Pregnancy
Conditions: Pregnancy Toxemia;   Hypertension;   Proteinuria
Interventions: Drug: methyldopa;   Drug: labetalol;   Drug: nifedipine;   Drug: clonidine
Outcome Measures: The achievement of target blood pressure obtained at every six weeks visits: weeks 20, 26, 32 and 38;   The incidence of superimposed preeclampsia;   Gestational age;   Birth weight < 10th centile for gestational age;   Serious perinatal complications
8 Not yet recruiting Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor
Conditions: Acute Cholecystitis;   Chronic Cholecystitis
Interventions: Procedure: TIVA - Hypotension;   Procedure: TIVA - Hypertension;   Procedure: TIVA - Bradycardia;   Procedure: TIVA - Tachycardia;   Procedure: INH - Hypotension;   Procedure: INH - Hypertension;   Procedure: INH - Bradycardia;   Procedure: INH - Tachycardia
Outcome Measures: Time to discharge from PACU;   Post operative Nausea and/or vomiting;   Visual Analog Scale Pain score;   ALDRETE Sedation Score;   Time to extubation
9 Unknown  Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
Condition: Pregnancy
Outcome Measures: Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment;   Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women
10 Recruiting Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
Outcome Measures: A pragmatic, streamlined randomized design to evaluate the efficacy of intensive SBP reduction and its effect on outcomes measures at 24 h and at 3 m from randomization in subjects with ICH;   Secondary outcomes

These studies may lead to new treatments and are adding insight into Albetol etiology and treatment.

A major focus of Albetol research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Albetol